Washington, DC, United States of America

Evan S Krygowski

USPTO Granted Patents = 17 

 

 

Average Co-Inventor Count = 13.7

ph-index = 10

Forward Citations = 200(Granted Patents)


Location History:

  • Foster City, CA (US) (2012)
  • Washington, CA (US) (2014)
  • Washington D.C., DC (US) (2015)
  • Belmont, CA (US) (2013 - 2016)
  • Washington, DC (US) (2013 - 2020)

Company Filing History:


Years Active: 2012-2020

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: The Innovation Journey of Evan S Krygowski: Pioneering Antiviral Compounds

Introduction: Evan S Krygowski, a prolific inventor based in Washington, DC, has made significant contributions to the field of antiviral compounds. With an impressive portfolio of 17 patents, Krygowski continues to push the boundaries of medical innovation.

Latest Patents: Among his recent patents, Krygowski has delved into the realm of antiviral compounds. His inventions focus on the development of compounds, compositions, and therapeutic methods for combating viruses. These patents showcase his dedication to advancing treatments for infectious diseases.

Career Highlights: Throughout his career, Krygowski has been associated with esteemed companies like Gilead Pharmasset LLC and Gilead Sciences, Inc. These organizations have provided him with a platform to pursue groundbreaking research in the field of pharmaceuticals. Krygowski's work has not only elevated his own profile but has also brought recognition to the companies he has been a part of.

Collaborations: Collaboration plays a vital role in driving innovation, and Krygowski has had the privilege of working alongside talented individuals in his field. Darryl Kato and John O Link are some of the coworkers who have shared in Krygowski's vision and contributed to the success of various projects. Together, they have formed a formidable team dedicated to revolutionizing antiviral therapies.

Conclusion: Evan S Krygowski's journey as an inventor exemplifies passion, dedication, and a relentless pursuit of scientific advancement. His focus on antiviral compounds stands as a testament to his commitment to improving global health outcomes. With a rich tapestry of patents and collaborations, Krygowski continues to shape the landscape of medical innovation, leaving a lasting impact on the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…